We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FITB
526
Fifth Third Bancorp
FITB
$52B
| $16.7M | 0.04% |
508,387
+464,887
| +1,069% | +$15.9M |
|
527
PUT
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
| $16.7M | 0.04% |
467,200
+84,100
| +22% | +$2.77M |
|
|
PSFE.WS
528
CALL
DELISTED
Paysafe Ltd Warrants
PSFE.WS
| $16.6M | 0.04% |
1,197,184
-857,816
| -42% | -$82.3K |
|
529
Mettler-Toledo International
MTD
$26.8B
| $16.6M | 0.04% |
11,482
+864
| +8% | +$1.16M |
|
530
Bloom Energy
BE
$52.6B
| $16.5M | 0.04% |
865,119
-25,618
| -3% | -$503K |
|
531
VF Corp
VFC
$6.68B
| $16.5M | 0.04% |
+598,186
| New | +$17.6M |
|
532
Fabrinet
FN
$17.1B
| $16.5M | 0.04% |
128,783
-31,977
| -20% | -$3.81M |
|
533
Cracker Barrel
CBRL
$1.2B
| $16.5M | 0.04% |
174,250
+126,695
| +266% | +$13.2M |
|
|
TWLV
534
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
| $16.5M | 0.04% |
1,632,155
| – | – |
|
535
TechTarget
TTGT
$246M
| $16.4M | 0.04% |
373,141
+181,796
| +95% | +$9.53M |
|
|
FRXB
536
DELISTED
Forest Road Acquisition Corp. II
FRXB
| $16.4M | 0.04% |
1,634,511
| – | – |
|
|
MORF
537
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $16.4M | 0.04% |
611,576
-105,464
| -15% | -$2.88M |
|
538
General Motors
GM
$74.7B
| $16.4M | 0.04% |
486,297
+371,220
| +323% | +$13.7M |
|
|
CNDA
539
DELISTED
Concord Acquisition Corp II
CNDA
| $16.3M | 0.04% |
1,640,548
| – | – |
|
|
MTVC
540
DELISTED
Motive Capital Corp II
MTVC
| $16.2M | 0.04% |
1,583,457
| – | – |
|
541
Ciena
CIEN
$55.3B
| $16.2M | 0.04% |
316,900
-357,131
| -53% | -$16.1M |
|
542
Global Ship Lease
GSL
$1.57B
| $16.1M | 0.04% |
968,627
-602,025
| -38% | -$10.4M |
|
|
NFYS
543
DELISTED
Enphys Acquisition Corp.
NFYS
| $16.1M | 0.04% |
1,601,824
| – | – |
|
|
UHG
544
DELISTED
United Homes Group
UHG
| $16M | 0.04% |
1,594,364
| – | – |
|
545
PUT
Pfizer
PFE
$140B
| $16M | 0.04% |
312,700
+2,400
| +0.8% | +$115K |
|
|
SCOB
546
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $16M | 0.04% |
1,580,467
| – | – |
|
|
SAVE
547
DELISTED
Spirit Airlines, Inc.
SAVE
| $16M | 0.04% |
819,764
+162,593
| +25% | +$3.34M |
|
548
Arcos Dorados Holdings
ARCO
$1.73B
| $15.9M | 0.04% |
1,904,710
+216,002
| +13% | +$1.62M |
|
|
OLPX
549
DELISTED
Olaplex Holdings
OLPX
| $15.9M | 0.04% |
+3,055,666
| New | +$18.1M |
|
|
TXNM
550
TXNM Energy Inc
TXNM
$6.47B
| $15.9M | 0.04% |
325,871
+88,985
| +38% | +$4.24M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.